Diabetic Medicine

• 

  Publication Venue For

  • Treatment of Type 2 diabetes mellitus in Chongqing of China: unaffordable care for the poor..  34:120-126. 2017
  • Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial..  33:243-251. 2016
  • Association of fasting glucose with subclinical cerebrovascular disease in older adults without Type 2 diabetes..  31:691-698. 2014
  • An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference..  28:673-680. 2011
  • The use of hypothetical scenarios and importance weightings when measuring the impact of diabetes on quality of life. A response to Brose et al..  26:1077-1079. 2009
  • Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes..  24:607-617. 2007
  • Patient and professional accuracy of recalled treatment decisions in out-patient consultations..  24:557-560. 2007
  • The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review..  23:445-448. 2006
  • Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes..  22:1016-1023. 2005
  • The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial results..  21:1082-1089. 2004
  • Ethnic differences and determinants of diabetes and central obesity among South Asians of Pakistan..  21:716-723. 2004
  • Novel hepatoselective insulin analogues: studies with covalently linked thyroxyl-insulin complexes.  15:928-936. 1998
  • The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain..  2:241-244. 1985
  • The Insulin Receptor-Its Function and Its Fate.  1:257-262. 1984
  • Phenotypic features of patients with Type 2 diabetes at increased risk of severe hypoglycemic events occurring before or after cardiovascular events 2019